U.S. court rules in favor of Mylan over Biogen's key MS drug patent
By Saumya JosephJune 18 (Reuters) - A U.S. district court on Thursday ruled in favor of generic drugmaker Mylan NV in a patent dispute over Biogen Inc's...
By Saumya JosephJune 18 (Reuters) - A U.S. district court on Thursday ruled in favor of generic drugmaker Mylan NV in a patent dispute over Biogen Inc's...